Literature DB >> 16028076

Silence of the transcripts: RNA interference in medicine.

Sailen Barik1.   

Abstract

Silencing of gene expression by ribonucleic acid (RNA), known as RNA interference (RNAi), is now recognized as a major means of gene regulation in biology. In this mechanism, small noncoding double-stranded RNA molecules knock down gene expression through a variety of mechanisms that include messenger RNA (mRNA) degradation, inhibition of mRNA translation, or chromatin remodeling. The posttranscriptional mechanism of RNAi has been embraced by researchers as a powerful tool for generating deficient phenotypes without mutating the gene. In parallel, exciting recent results have promised its application in disease therapy. This review aims to summarize the current knowledge in this area and provide a roadmap that may eventually launch RNAi from the research bench to the medicine chest.

Mesh:

Substances:

Year:  2005        PMID: 16028076     DOI: 10.1007/s00109-005-0690-0

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  128 in total

1.  Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference.

Authors:  S Parrish; J Fleenor; S Xu; C Mello; A Fire
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

2.  Inducible shRNA expression for application in a prostate cancer mouse model.

Authors:  Frank Czauderna; Ansgar Santel; Michael Hinz; Melanie Fechtner; Birgit Durieux; Gerald Fisch; Frauke Leenders; Wolfgang Arnold; Klaus Giese; Anke Klippel; Jörg Kaufmann
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

3.  RNA interference in mammalian cells by chemically-modified RNA.

Authors:  Dwaine A Braasch; Susan Jensen; Yinghui Liu; Kiran Kaur; Khalil Arar; Michael A White; David R Corey
Journal:  Biochemistry       Date:  2003-07-08       Impact factor: 3.162

4.  Induction of an interferon response by RNAi vectors in mammalian cells.

Authors:  Alan J Bridge; Stephanie Pebernard; Annick Ducraux; Anne-Laure Nicoulaz; Richard Iggo
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

5.  Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways.

Authors:  Dianne S Schwarz; György Hutvágner; Benjamin Haley; Phillip D Zamore
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

6.  Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.

Authors:  Cédric Raoul; Toufik Abbas-Terki; Jean-Charles Bensadoun; Sandrine Guillot; Georg Haase; Jolanta Szulc; Christopher E Henderson; Patrick Aebischer
Journal:  Nat Med       Date:  2005-03-13       Impact factor: 53.440

7.  CXCR4 regulates growth of both primary and metastatic breast cancer.

Authors:  Matthew C P Smith; Kathryn E Luker; Joel R Garbow; Julie L Prior; Erin Jackson; David Piwnica-Worms; Gary D Luker
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

8.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

9.  Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania.

Authors:  Kelly A Robinson; Stephen M Beverley
Journal:  Mol Biochem Parasitol       Date:  2003-05       Impact factor: 1.759

10.  Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression.

Authors:  Christophe Butticaz; Angela Ciuffi; Miguel Muñoz; Jérôme Thomas; Alan Bridge; Stephanie Pebernard; Richard Iggo; Pascal Meylan; Amalio Telenti
Journal:  Antivir Ther       Date:  2003-10
View more
  23 in total

1.  Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer.

Authors:  Warefta Hasan; Kevin Chu; Anuradha Gullapalli; Stuart S Dunn; Elizabeth M Enlow; J Christopher Luft; Shaomin Tian; Mary E Napier; Patrick D Pohlhaus; Jason P Rolland; Joseph M DeSimone
Journal:  Nano Lett       Date:  2011-12-21       Impact factor: 11.189

Review 2.  Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs.

Authors:  Fang Liu; Chunfang Wang; Yuantao Gao; Xiao Li; Feng Tian; Yongtao Zhang; Mingyang Fu; Pengfei Li; Yali Wang; Fei Wang
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

3.  Inhibition of HBV replication by delivering the dual-gene expression vector pHsa-miR16-siRNA in HepG2.2.15 cells.

Authors:  Wei Wei; Su-Fei Wang; Bing Yu; Ming Ni
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

4.  Viral infection of the lungs through the eye.

Authors:  Vira Bitko; Alla Musiyenko; Sailen Barik
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

5.  Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery.

Authors:  Bérangère Langlet-Bertin; Christian Leborgne; Daniel Scherman; Burkhard Bechinger; A James Mason; Antoine Kichler
Journal:  Pharm Res       Date:  2010-07       Impact factor: 4.200

6.  Downregulation of IGF-IR expression by RNAi inhibits proliferation and enhances chemosensitization of human colon cancer cells.

Authors:  Kamal Yavari; Mohammad Taghikhani; Mohammad Ghannadi Maragheh; Seyed A Mesbah-Namin; Mohammad Hossein Babaei
Journal:  Int J Colorectal Dis       Date:  2009-08-11       Impact factor: 2.571

7.  RNAi-dependent and -independent antiviral phenotypes of chromosomally integrated shRNA clones: role of VASP in respiratory syncytial virus growth.

Authors:  Alla Musiyenko; Vira Bitko; Sailen Barik
Journal:  J Mol Med (Berl)       Date:  2007-03-10       Impact factor: 4.599

8.  Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells.

Authors:  Alla Musiyenko; Vira Bitko; Sailen Barik
Journal:  J Mol Med (Berl)       Date:  2008-01-12       Impact factor: 4.599

9.  Self-assembled Micelle Interfering RNA for Effective and Safe Targeting of Dysregulated Genes in Pulmonary Fibrosis.

Authors:  Pyoung Oh Yoon; Jin Wook Park; Chang-Min Lee; Sung Hwan Kim; Han-Na Kim; Youngho Ko; Seon Joo Bae; Sungil Yun; Jun Hong Park; Taewoo Kwon; Woo Seok Kim; Jiyoung Lee; Qing Lu; Hye-Ryun Kang; Won-Kyung Cho; Jack A Elias; Joo-Sung Yang; Han-Oh Park; Kyuhong Lee; Chun Geun Lee
Journal:  J Biol Chem       Date:  2016-01-27       Impact factor: 5.157

10.  Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways.

Authors:  Jenny K W Lam; Wanling Liang; Yun Lan; Poulami Chaudhuri; Michael Y T Chow; Katarzyna Witt; Laila Kudsiova; A James Mason
Journal:  J Control Release       Date:  2011-11-26       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.